MTOR and early-onset autosomal dominant Alzheimer disease: Additionally, dichotomine B is a key bioactive compound that mitigates Alzheimer’s disease pathology by inducing autophagy and activating the PI3K/Akt/mTOR and AMPK signaling pathways [33].